These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27483430)
1. Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible? Seung KJ; Franke M; Linton SW PLoS Med; 2016 Aug; 13(8):e1002062. PubMed ID: 27483430 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Drug Resistant Tuberculosis in Sanatoria of North Korea. Jung J; Jegal Y; Ki M; Shin YJ; Kim CT; Shim TS; Sung N J Korean Med Sci; 2017 Jul; 32(7):1105-1110. PubMed ID: 28581266 [TBL] [Abstract][Full Text] [Related]
3. Tuberculosis in North Korea. Perry S; Linton H; Schoolnik G Science; 2011 Jan; 331(6015):263. PubMed ID: 21252318 [No Abstract] [Full Text] [Related]
4. Public enemy number one. Stone R Science; 2013 Apr; 340(6131):422-5. PubMed ID: 23620029 [No Abstract] [Full Text] [Related]
5. The growing problem of multidrug-resistant tuberculosis in North Korea. Seung KJ; Linton SW PLoS Med; 2013; 10(7):e1001486. PubMed ID: 23935457 [TBL] [Abstract][Full Text] [Related]
6. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model. Cho H; Park Y; Seok J; Yeom JS; Choi JY; Kim HJ; Kang YA; Lee J BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34620614 [TBL] [Abstract][Full Text] [Related]
7. North Korea. New tuberculosis lab hailed as breakthrough in health diplomacy. Stone R Science; 2010 Mar; 327(5971):1312-3. PubMed ID: 20223956 [No Abstract] [Full Text] [Related]
8. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design. Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290 [TBL] [Abstract][Full Text] [Related]
9. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center. Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663 [TBL] [Abstract][Full Text] [Related]
10. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis. Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890 [TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant tuberculosis in children from 2003 to 2005: a brief report. Shah I Indian J Med Microbiol; 2012; 30(2):208-11. PubMed ID: 22664439 [TBL] [Abstract][Full Text] [Related]
12. Changes in treatment outcomes of multidrug-resistant tuberculosis. Kwak N; Kim HR; Yoo CG; Kim YW; Han SK; Yim JJ Int J Tuberc Lung Dis; 2015 May; 19(5):525-30. PubMed ID: 25868019 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series. Judge D; Krause V Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406 [TBL] [Abstract][Full Text] [Related]
14. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant tuberculosis: a review of the 23 cases treated by the Saint-Pierre University Hospital (Brussels). Jacob V; Robert L; Lebrun C; Van Laethem Y; Sergysels R Acta Clin Belg; 2009; 64(2):113-9. PubMed ID: 19432023 [TBL] [Abstract][Full Text] [Related]
16. Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo. Shanks L; Masumbuko EW; Ngoy NM; Maneno M; Bartlett S; Thi SS; Shah T Int J Tuberc Lung Dis; 2012 Aug; 16(8):1066-8. PubMed ID: 22565108 [TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
18. [Risk factors for multidrug-resistant tuberculosis in the city of Kinshasa in the Democratic Republic of Congo]. Misombo-Kalabela A; Nguefack-Tsague G; Kalla GC; Ze EA; Diangs K; Panda T; Kebela I; Fueza SB; Magazani N; Mbopi-Kéou FX Pan Afr Med J; 2016; 23():157. PubMed ID: 27516818 [TBL] [Abstract][Full Text] [Related]
19. USA and North Korea work together on tuberculosis. Gee A Lancet; 2010 May; 375(9729):1862. PubMed ID: 20521344 [No Abstract] [Full Text] [Related]
20. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related] [Next] [New Search]